Shannon Thyme Klinger - 27 Feb 2025 Form 4 Insider Report for Moderna, Inc. (MRNA)

Role
Chief Legal Officer
Signature
/s/ James Dillon, as Attorny-in-Fact
Issuer symbol
MRNA
Transactions as of
27 Feb 2025
Transactions value $
$-93,319
Form type
4
Filing time
28 Feb 2025, 16:25:08 UTC
Previous filing
14 Feb 2025
Next filing
03 Mar 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MRNA Common Stock Options Exercise +3,094 +14.2% 24,861 27 Feb 2025 Direct F1, F2
transaction MRNA Common Stock Tax liability $-50,236 -1,496 -6.02% $33.58 23,365 27 Feb 2025 Direct F3
transaction MRNA Common Stock Options Exercise +2,653 +11.4% 26,018 27 Feb 2025 Direct F1
transaction MRNA Common Stock Tax liability $-43,083 -1,283 -4.93% $33.58 24,735 27 Feb 2025 Direct F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction MRNA Restricted Stock Units Options Exercise $0 -3,094 -25% $0.000000 9,283 27 Feb 2025 Common Stock 3,094 Direct F1, F4
transaction MRNA Restricted Stock Units Options Exercise $0 -2,653 -100% $0.000000 0 27 Feb 2025 Common Stock 2,653 Direct F1, F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Restricted stock units convert into common stock on a one-for-one basis.
F2 Includes 342 shares acquired under the Moderna, Inc. 2018 Employee Stock Purchase Plan on December 13, 2024.
F3 Represents shares withheld at the election of the Reporting Person to satisfy tax withholding obligations in connection with the vest of restricted stock units.
F4 25% of the shares subject to this restricted stock unit award vested on February 27, 2025 with the remainder vesting in twelve (12) equal quarterly installments thereafter.
F5 25% of the shares subject to this restricted stock unit award vested on May 27, 2024 with the remainder vesting in three (3) equal quarterly installments thereafter.